ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cresa Boston Welcomes RJ Panzo of T3, Strengthening Life Sciences Practice

Strategic senior hire is the latest in Cresa's efforts to deepen industry expertise and expand services

BOSTON, MA / ACCESSWIRE / July 12, 2022 / The Boston office of Cresa, the world's largest tenant-only commercial real estate firm, is pleased to announce that RJ Panzo has joined their team as Senior Vice President of Life Sciences. This addition is the latest development in Cresa's multiyear strategy to strengthen their life sciences practice and underscore their commitment to serving the scientific community.

Cresa Boston, Tuesday, July 12, 2022, Press release picture

With a background as a scientist and lab operator, Panzo will bring critical end-user perspective to support Cresa's life sciences clients. Panzo will collaborate with Cresa's real estate advisors, consultants, and strategists to provide industry-specific insights and creative solutions to our clients and partners across Greater Boston.

"To have RJ join Cresa is a game changer for our team," said Adam Subber, Managing Principal at Cresa Boston. "Life sciences organizations have so much to consider in the market, and RJ's experience and perspective will be a strong asset for our clients moving forward. This industry has dominated the market for the last few years, and there's still so much opportunity for our clients."

"Cresa has a seasoned team and is on a great trajectory," said Panzo. "I'm thrilled to be joining this group, and I'm looking forward to the chance to collaborate with the team and grow the life sciences practice together."

With the addition of Panzo, Cresa's life sciences team is comprised of a unique combination of advisors, lab and workplace strategists, project managers, and data consultants to provide a deeply integrated and holistic look at real estate strategies and opportunities. As the Greater Boston market continues to shift and evolve, this type of multidisciplinary insight will be critical in informing sound business decisions.

Panzo joins Cresa from T3 Advisors, A Savills Company. As Corporate Managing Director of Lab and Facility Planning with T3, he developed and executed lab operations and real estate strategies for life sciences companies at all stages of growth. Before T3, Panzo worked in research, project management, and operations roles at a number of prominent life sciences and biotech organizations in Greater Boston.

About Cresa

Cresa is the world's only global commercial real estate advisory firm that exclusively represents occupiers and specializes in the delivery of fully integrated real estate solutions. Our purpose is to think beyond space, strengthening those we serve and enhancing the quality of life for our clients. Delivered across every industry, Cresa's services include Transaction Management, Workplace Solutions, Project Management, Consulting, Lease Administration, Technology, Investment Banking & Capital Markets and Portfolio Solutions. In partnership with London-based Knight Frank, Cresa provides service through 16,000 people, across 380 offices in 51 territories. For more information, please visit cresa.com.

Media Contact

Susan Shelby, FSMPS, CPSM
Rhino PR for Cresa Boston
cresaboston@rhinopr.com
978.985.4541

SOURCE: Cresa Boston



View source version on accesswire.com:
https://www.accesswire.com/708142/Cresa-Boston-Welcomes-RJ-Panzo-of-T3-Strengthening-Life-Sciences-Practice

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.